The levels of serum hepcidin in patients with non-small cell lung cancer, breast cancer, and pancreatic cancer are significantly higher compared with those of healthy individuals or those with benign disease [39–41]. The gene discussed is HAMP; the disease is non-small cell lung carcinoma.